Compare Moderna, Inc. (MRNA) vs Vistra Corp (VST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Moderna, Inc. vs Vistra Corp — how do they compare? Moderna, Inc. trades at $59.72 (market cap $23.60B), while Vistra Corp trades at $161.99 (market cap $53.27B). The key difference: Vistra Corp is far larger — about 2.3× Moderna, Inc.'s market cap, and Vistra Corp pays a 0.58% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals.
| MRNA | VST | |
|---|---|---|
Market Cap | $23.60B | $53.27B |
Sector | Health | Technology |
52-Week High | $81.80 | $217.92 |
52-Week Low | $22.36 | $134.71 |
Enterprise Value | $19.70B | $75.03B |
Dividend Yield | — | 0.58% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →About Vistra Corp
Vistra is a leading integrated retail electricity and power generation company that serves as a critical infrastructure provider for the digital economy. It operates a diversified portfolio of zero-carbon nuclear and renewable assets alongside a massive, flexible natural gas fleet, positioning it as an indispensable partner for energy-intensive AI data centers and industrial electrification.
Read more on VST →
